ERAXIS 50 mg/15mL (Anidulafungin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 50 mg/15mL

ERAXIS 50 mg/15mL is a lyophilized powder for injection containing anidulafungin. It is used for treating fungal infections, including invasive candidiasis. This intravenous medication is designed for single-use administration.

Strength

50 mg/15mL

Pack Size

15 mL in 1 VIAL, SINGLE-USE (0049-0114-28)

Manufacturer / TM Owner

Roerig

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ERAXIS 50 mg/15mL is primarily used for the treatment of fungal infections, such as invasive candidiasis. It is an antifungal medication that works by targeting the fungal cell wall, helping to combat the infection. This medication is often prescribed when other treatments are not suitable or effective. What is ERAXIS used for? It is used for managing serious fungal infections in patients who require intravenous antifungal therapy.

Side Effects

Common effects of ERAXIS 50 mg/15mL may include infusion-related reactions, such as fever, chills, or rash. Some patients may experience gastrointestinal issues like nausea or diarrhea. These effects are generally mild and temporary, but severe reactions should be reported to a healthcare provider immediately.

Precautions & Warnings

ERAXIS 50 mg/15mL should be handled with care, ensuring proper reconstitution and administration procedures are followed. It is important to inform healthcare providers of any allergies or pre-existing conditions before use. This medication is for intravenous use only and should be administered by a healthcare professional.

Avoid Interactions

ERAXIS 50 mg/15mL may interact with certain medications, including those metabolized by the liver. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances that affect liver function should be avoided during treatment.

References

Frequently Asked Questions

ERAXIS 50 mg/15mL is used for treating fungal infections, such as invasive candidiasis, in patients who require intravenous antifungal therapy.

ERAXIS 50 mg/15mL is administered intravenously by a healthcare professional after proper reconstitution of the lyophilized powder.

Common side effects may include infusion-related reactions like fever, chills, or rash, as well as gastrointestinal issues such as nausea or diarrhea.

Potential interactions with other medications should be discussed with a healthcare provider to ensure safe and effective treatment.

ERAXIS 50 mg/15mL should be used under the guidance of a healthcare provider, who will consider individual health conditions and potential allergies.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.